Life Technologies and DaAn Gene announce amalgamation

January 27, 2012

LCGC Asia Pacific eNews

LCGC Asia Pacific eNews-01-27-2012, Volume 0, Issue 0

Life Technologies Corporation has announced that they have signed an agreement with DaAn Gene, China?s premier bio-tech enterprise, to form Life Technologies DaAn Diagnostics.

Life Technologies Corporation has announced that they have signed an agreement with DaAn Gene, China’s premier bio-tech enterprise, to form Life Technologies DaAn Diagnostics.

Based in Guangzhou, Life Technologies DaAn Diagnostics will develop and produce a portfolio of molecular diagnostic assays. It is expected that the move will play a key role in disease prevention. The venture allows both companies to expand the use of capillary electrophoresis technology into the Chinese clinical diagnostics market.

Gregory Lucier, chairman and CEO of Life Technologies, said, “This joint venture strengthens the foundation of our clinical diagnostics business and represents a big leap forward for our business in China. The products will play a key role in disease prevention and therapy selection.”

Zhou Xinyu, CEO of DaAn Gene, commented, “Today, the cooperation with Life Technologies introduces DaAn’s products to the global marketplace, while bringing Life’s superior technologies into China’s IVD market. Together, we are working towards becoming a premium IVD product supplier that has global impact.”

For more information please visit ref="http://www.lifetechnologies.com">www.lifetechnologies.com